Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
11 Apr 24
DEF 14A
Definitive proxy
11 Apr 24
8-K
Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors
13 Mar 24
S-8
Registration of securities for employees
21 Feb 24
10-K
2023 FY
Annual report
21 Feb 24
8-K
Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24
8-K
Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and non-GAAP Gross Margin Guidance
8 Jan 24
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
2 Jan 24
8-K
Entry into a Material Definitive Agreement
11 Dec 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Outset Medical Reports Third Quarter 2023 Financial Results
7 Nov 23
8-K
Outset Medical Reports Preliminary Third Quarter 2023 Financial Results
12 Oct 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
8-K
Outset Medical Reports Second Quarter 2023 Financial Results
2 Aug 23
8-K
Other Events
7 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
1 Jun 23
SD
Conflict minerals disclosure
31 May 23
10-Q
2023 Q1
Quarterly report
3 May 23
8-K
Outset Medical Reports First Quarter 2023 Financial Results
3 May 23
DEFA14A
Additional proxy soliciting materials
13 Apr 23
DEF 14A
Definitive proxy
13 Apr 23
S-8
Registration of securities for employees
13 Feb 23
10-K
2022 FY
Annual report
13 Feb 23
8-K
Outset Medical Reports Fourth Quarter and Full Year 2022 Financial Results
13 Feb 23
8-K
Outset Medical Reports Expected Fourth Quarter and Full Year 2022 Revenue, Provides 2023 Revenue and non-GAAP Gross Margin Guidance
9 Jan 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
Outset Medical Reports Third Quarter 2022 Financial Results
8 Nov 22
8-K
Outset Medical Secures Up To $300 Million in Debt Financing
4 Nov 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
8-K
Reports Second Quarter 2022 Financial Results and Provides 2022 Guidance
1 Aug 22
8-K
Outset Medical Announces Shipment Hold on New Tablo Systems for Home Use Pending FDA Review and Clearance of Recent 510(K) Submission
13 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
1 Jun 22
10-Q
2022 Q1
Quarterly report
4 May 22
8-K
Outset Medical Reports First Quarter 2022 Financial Results
4 May 22
DEFA14A
Additional proxy soliciting materials
25 Apr 22
8-K
Outset Medical Names Business Leader Dale E. Jones to Board of Directors
25 Apr 22
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 22
S-8
Registration of securities for employees
23 Feb 22
10-K
2021 FY
Annual report
23 Feb 22
Latest ownership filings
SC 13G/A
AMERIPRISE FINANCIAL INC
10 Apr 24
4
Marc Nash
15 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
4
BRENT D. LANG
13 Mar 24
3
BRENT D. LANG
13 Mar 24
4
Nabeel Ahmed
4 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
4
Nabeel Ahmed
26 Feb 24
4
Leslie Trigg
26 Feb 24
4
Steven S. Williamson
16 Feb 24
4
Leslie Trigg
16 Feb 24
4
Jean-Olivier Racine
16 Feb 24
4
Marc Nash
16 Feb 24
4
John L. Brottem
16 Feb 24
4
Nabeel Ahmed
16 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
SC 13G
AMERIPRISE FINANCIAL INC
14 Feb 24
SC 13G
T. Rowe Price Investment Management, Inc.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
Bellevue Group AG
13 Feb 24
SC 13G
MORGAN STANLEY
9 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
SC 13G/A
BlackRock Inc.
26 Jan 24
SC 13G/A
JPMORGAN CHASE & CO
23 Jan 24
4
Steven S. Williamson
17 Jan 24
4
Leslie Trigg
17 Jan 24
4
Jean-Olivier Racine
17 Jan 24
4
Stacey L. Porter
17 Jan 24
4
Marc Nash
17 Jan 24
4
John L. Brottem
17 Jan 24
4
Nabeel Ahmed
17 Jan 24
144
Notice of proposed sale of securities
16 Jan 24
144
Notice of proposed sale of securities
16 Jan 24
144
Notice of proposed sale of securities
16 Jan 24
144
Notice of proposed sale of securities
16 Jan 24